Statin Recapture Therapy before Coronary Artery Bypass Grafting Trial: Rationale and study design of a multicenter, randomized, double-blinded controlled clinical trial

American Heart Journal

Volumn 170, Issue 1, 2015, Pages 46-54.e2

  Liakopoulos, Oliver J ^a   Kuhn, Elmar W ^a   Hellmich, Martin ^a   Kuhr, Kathrin ^a   Krause, Petra ^a   Reuter, Hannes ^a   Thurat, Meike ^b   Choi, Yeong Hoon ^a   Wahlers, Thorsten ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; CARDIOTONIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HEART INFARCTION; HEART MUSCLE INJURY; HEART MUSCLE REVASCULARIZATION; HOSPITAL; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEW-ONSET ATRIAL FIBRILLATION; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; STUDY DESIGN; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; CORONARY ARTERY DISEASE; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; PROCEDURES; STROKE; TREATMENT OUTCOME;

CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DOUBLE-BLIND METHOD; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; SIMVASTATIN; STROKE; TREATMENT OUTCOME;

EID: 84931573204     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2015.04.015     Document Type: Article

References (40)

1. M.-C.I. Investigators, J.H. Alexander, and R.W. Emery Jr. Efficacy and safety of pyridoxal 5′-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial JAMA 299 15 2008 1777 1787
2. S.W. Boyce, C. Bartels, and R. Bolli Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study J Thorac Cardiovasc Surg 126 2 2003 420 427
3. A.K. Funkat, A. Beckmann, and J. Lewandowski Cardiac surgery in Germany during 2011: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery Thorac Cardiovasc Surg 60 6 2012 371 382
4. R.M. Mentzer Jr., C. Bartels, and R. Bolli Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study Ann Thorac Surg 85 4 2008 1261 1270
5. P.W. Serruys, M.C. Morice, and A.P. Kappetein Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 10 2009 961 972
6. E.D. Verrier, S.K. Shernan, and K.M. Taylor Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial JAMA 291 19 2004 2319 2327
7. J.J. Brugts, T. Yetgin, and S.E. Hoeks The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 2009 b2376
8. Z. Reiner, A.L. Catapano, and G. De Backer ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 14 2011 1769 1818
9. G.L. Knatterud, Y. Rosenberg, and L. Campeau Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators Circulation 102 2 2000 157 165
10. A. Ludman, V. Venugopal, and D.M. Yellon Statins and cardioprotection - more than just lipid lowering? Pharmacol Ther 122 1 2009 30 43
11. U. Laufs, and O. Adam Acute effects of statins J Am Coll Cardiol 59 1 2012 71 73
12. G. Patti, V. Pasceri, and G. Colonna Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 12 2007 1272 1278
13. G. Patti, C.P. Cannon, and S.A. Murphy Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies Circulation 123 15 2011 1622 1632
14. E.W. Kuhn, O.J. Liakopoulos, and S. Stange Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients Eur J Cardiothorac Surg 45 1 2014 17 26 discussion 26
15. O.J. Liakopoulos, Y.H. Choi, and P.L. Haldenwang Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: a meta-analysis of over 30,000 patients Eur Heart J 29 12 2008 1548 1559
16. V.A. Mannacio, D. Iorio, and V. De Amicis Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial J Thorac Cardiovasc Surg 136 6 2008 1541 1548
17. C. Antoniades, M. Demosthenous, and S. Reilly Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment J Am Coll Cardiol 59 1 2012 60 70
18. M. Thielmann, M. Neuhauser, and A. Marr Lipid-lowering effect of preoperative statin therapy on postoperative major adverse cardiac events after coronary artery bypass surgery J Thorac Cardiovasc Surg 134 5 2007 1143 1149
19. G. Di Sciascio, G. Patti, and V. Pasceri Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial J Am Coll Cardiol 54 6 2009 558 565
20. K. Mensah, M.M. Mocanu, and D.M. Yellon Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? J Am Coll Cardiol 45 8 2005 1287 1291
21. R. Schulz Pleiotropic effects of statins: acutely good, but chronically bad? J Am Coll Cardiol 45 8 2005 1292 1294
22. E.W. Kuhn, O.J. Liakopoulos, and A.C. Deppe Rosuvastatin reloading before cardiac surgery with cardiopulmonary bypass Eur Surg Res 50 1 2013 1 13
23. S.G. Ellis, and S. Anwaruddin Recapturing the magic: revisiting the pleiotropic effects of statins in percutaneous coronary revascularization J Am Coll Cardiol 54 6 2009 566 568
24. G. Patti, M. Chello, and D. Candura Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study Circulation 114 14 2006 1455 1461
25. L.D. Hillis, P.K. Smith, and J.L. Anderson 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 124 23 2011 e652 e735
26. K.A.J. Thygesen, A.S. Jaffe, and M.L. Simoons Third universal definition of myocardial infarction J Am Coll Cardiol 60 16 2012 1581 1598
27. J.D. Easton, J.L. Saver, and G.W. Albers Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists Stroke 40 6 2009 2276 2293
28. J.L. Januzzi, K. Lewandrowski, and T.E. MacGillivray A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery J Am Coll Cardiol 39 9 2002 1518 1523
29. A.A. Mohammed, A.K. Agnihotri, and R.R. van Kimmenade Prospective, comprehensive assessment of cardiac troponin T testing after coronary artery bypass graft surgery Circulation 120 10 2009 843 850
30. R.C. Pasternak, S.C. Smith Jr., and C.N. Bairey-Merz ACC/AHA/NHLBI clinical advisory on the use and safety of statins J Am Coll Cardiol 40 3 2002 567 572
31. G.B. Mancini, S. Baker, and J. Bergeron Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference Can J Cardiol 27 5 2011 635 662
32. O. Friberg, R. Svedjeholm, and B. Soderquist Local gentamicin reduces sternal wound infections after cardiac surgery: a randomized controlled trial Ann Thorac Surg 79 1 2005 153 161 discussion 161-2
33. A.J. Mangram, T.C. Horan, and M.L. Pearson Guideline for prevention of surgical site infection, 1999 Am J Infect Control 27 2 1999 97 134
34. O.J. Liakopoulos, Y.H. Choi, and E.W. Kuhn Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review J Thorac Cardiovasc Surg 138 3 2009 678 686 3
35. E.W. Kuhn, O.J. Liakopoulos, and S. Stange Meta-analysis of patients taking statins before revascularization and aortic valve surgery Ann Thorac Surg 96 4 2013 1508 1516
36. A.J. Ludman, D.J. Hausenloy, and G. Babu Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial Basic Res Cardiol 106 6 2011 1387 1395
37. A.K. Gitt, C. Junger, and W. Smolka Prevalence and overlap of different lipid abnormalities in statin-treated patients at high cardiovascular risk in clinical practice in Germany Clin Res Cardiol 99 11 2010 723 733
38. J.A. Finegold, C.H. Manisty, and B. Goldacre What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice Eur J Prev Cardiol 21 4 2014 464 474
39. O. Schouten, E. Boersma, and S.E. Hoeks Fluvastatin and perioperative events in patients undergoing vascular surgery N Engl J Med 361 10 2009 980 989
40. A. Kulik, and M. Ruel Statins and coronary artery bypass graft surgery: preoperative and postoperative efficacy and safety Expert Opin Drug Saf 8 5 2009 559 571